Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights
Yahoo/Zacks.com
Mon, 06/23/14 - 07:52 pm
Sanofi
Merrimack Pharmaceuticals
MM-121
Three Companies That Want to Cure Pancreatic Cancer
Yahoo/247WallStreet
Thu, 05/22/14 - 10:10 am
pancreatic cancer
Celgene
Abraxane
Incyte
ruxolitinib
Merrimack Pharmaceuticals
MM-398
Merrimack Pharmaceuticals: Setting The Record Straight On MM 398
Seeking Alpha
Fri, 05/16/14 - 03:46 pm
Merrimack Pharmaceuticals
MM-398
metastatic pancreatic cancer
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Mon, 05/5/14 - 05:02 pm
Merrimack Pharmaceuticals
pancreatic cancer
MM-398
Gemzar
Eli Lilly
Celgene
Abraxane
Merrimack cancer drug combination improves survival in study
Yahoo/Reuters
Thu, 05/1/14 - 08:27 am
Merrimack Pharmaceuticals
metastatic pancreatic cancer
MM-398
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Motley Fool
Thu, 04/10/14 - 11:13 pm
Merrimack Pharmaceuticals
Sunesis
pancreatic cancer
MM-398
vosaroxin
3 Small Cap Biotechs Developing Novel Cancer Treatments
Motley Fool
Wed, 02/19/14 - 12:56 pm
Inovio
VGX-3100
Cervical Intraepithelial Neoplasia
MM-398
Merrimack Pharmaceuticals
acute myeloid leukemia
vosaroxin
Sunesis
Preclinical Study Results of Merrimack's MM-141 Published in Molecular Cancer Therapeutics
Yahoo/Benzinga
Tue, 02/18/14 - 08:58 am
Merrimack Pharmaceuticals
MM-141
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
24/7 Wall St
Tue, 01/7/14 - 11:47 am
Celldex Therapeutics
Immunomedics
Keryx
Merrimack Pharmaceuticals
Protalix BioTherapeutics
Merrimack announces clinical data from Phase 1 study of MM-302
The Fly on the Wall
Fri, 12/13/13 - 10:22 am
MM-302
Merrimack Pharmaceuticals
HER-2 postive breast cancer
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem
Seeking Alpha
Wed, 12/4/13 - 09:24 am
Inovio
Merrimack Pharmaceuticals
NeoStem
VGX-3100
MM-398
AMR-001
3 Biotech Stocks That Soared on Tuesday
Wall St Cheat Sheet
Wed, 11/27/13 - 09:56 am
Clovis Oncology
Echo Therapeutics
Merrimack Pharmaceuticals
Keep an Eye on Pacific Biosciences, Epizyme, and Merrimack Today
Motley Fool
Fri, 11/22/13 - 10:21 am
Pacific Biosciences
Epizyme
Merrimack Pharmaceuticals
Merrimack - Not Bad News?
Seeking Alpha
Thu, 10/31/13 - 08:52 am
Merrimack Pharmaceuticals
MM-121
ovarian cancer
Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies
Seeking Alpha
Fri, 10/18/13 - 10:51 am
Celldex
ImmunoCellular Therapeutics
Enanta
Merrimack Pharmaceuticals
Vanda
Merrimack Progresses With MM-398
Yahoo/Zacks
Fri, 08/30/13 - 08:45 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Merrimack Study Data Published
Yahoo/Zacks
Sat, 08/24/13 - 11:36 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 08/17/13 - 10:47 am
Merrimack Pharmaceuticals
MannKind
Synta Pharmaceuticals
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 08/10/13 - 12:24 pm
Dendreon
Merrimack Pharmaceuticals
Novavax
Merrimack Progresses with MM-111
Yahoo/Zacks
Sat, 07/27/13 - 11:13 am
Merrimack Pharmaceuticals
cancer
gastric cancer
esophageal cancer
gastroesophageal cancer
Pages
« first
‹ previous
1
2
3
4
next ›
last »